tiprankstipranks
Annovis Bio (ANVS)
NYSE:ANVS
US Market

Annovis Bio (ANVS) Income Statement

Compare
604 Followers

Annovis Bio Income Statement

Last quarter (Q3 2024), Annovis Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Annovis Bio's net income was $-12.64B. See Annovis Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 45.04M$ 25.51M$ 14.50M$ 5.48M$ 870.55K
Depreciation and Amortization
$ 1.00$ 25.51M$ 14.54M$ 6.64M$ 1.61M
EBITDA
$ -45.04M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income
$ -45.04M$ -25.51M$ -14.54M$ -6.64M$ -1.61M
Other Income/Expenses
$ -11.17M$ 182.71K$ 50.09K$ 1.18M$ 614.64K
Pretax Income
$ -56.20M$ -25.33M$ -14.49M$ -5.46M$ -990.98K
Net Income
$ -56.20M$ -25.15M$ -14.44M$ -4.26M$ -296.84K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -6.23$ -3.08$ -1.89$ -0.67$ -0.07
Diluted EPS
$ -6.23$ -3.08$ -1.89$ -0.67$ -0.07
Weighted Average Shares Outstanding
9.02M 8.16M 7.63M 6.31M 4.50M
Weighted Average Shares Outstanding (Diluted)
9.02M 8.16M 7.63M 6.31M 4.50M
Currency in USD

Annovis Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis